Diagnostic potential of serum proteomic patterns in prostate cancer

Journal of Urology

Volumn 170, Issue 2 I, 2003, Pages 442-446

  Bañez, Lionel L ^a   Prasanna, Premkala ^a   Sun, Leon ^a   Ali, Amina ^a   Zou, Zhiqiang ^a   Adam, Bao Ling ^b   McLeod, David G ^c   Moul, Judd W ^a,c   Srivastava, Shiv ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Prostate; Prostatic neoplasms; Proteins; Proteomics; Spectrometry, mass, matrix assisted laser desorption ionization

Indexed keywords

BIOLOGICAL MARKER; PLASMA PROTEIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; ALGORITHM; ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPPER METAL AFFINITY CAPTURE ARRAY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN DETERMINATION; PROTEOMICS; TECHNOLOGY; WEAK CATION EXCHANGE ARRAY;

EID: 1642557289     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000069431.95404.56     Document Type: Article

References (19)

1. Jemal, A., Thomas, A., Murray, T. and Thun, M.: Cancer Statistics, 2002. CA Cancer J Clin, 52: 23, 2002
2. Barry, M. J.: Clinical practice. Prostate-specific antigen testing for early diagnosis of prostate cancer. N Engl J Med, 344: 1373, 2001
3. Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology, 14: 267, 2000
4. Weber, B. L.: Cancer genomics. Cancer Cell, 1: 37, 2002
5. Ramaswamy, S. and Golub, T. R.: DNA microarrays in clinical oncology. J Clin Oncol, 20: 1932, 2002
6. Chong, B. E., Hamler, R. L., Lubman, D. M., Ethier, S. P., Rosenspire, A. J. and Miller, F. R.: Differential screening and mapping of proteins from premalignant and cancer cell lines using nonporous reverse-phase HPLC coupled with mass spectrometric analysis. Anal Chem, 73: 1219, 2001
7. Ferrari, L., Seraglia, R., Rossi, C. R., Bertazzo, A., Lise, M., Allegri, G. et al: Protein profiles in sera of patients with malignant cutaneous melanoma. Rapid Commun Mass Spectrom, 14: 1149, 2000
8. Keough, T., Lacey, M. P., Fieno, A. M., Grant, R. A., Sun, Y., Bauer, M. D. et al: Tandem mass spectrometry methods for definitive protein identification in proteomics research. Electrophoresis, 21: 2252, 2000
9. von Eggeling, F., Junker, K., Fiedle, W., Wollscheid, V., Durst, M., Claussen, U. et al: Mass spectrometry meets chip technology: a new proteomic tool in cancer research? Electrophoresis, 22: 2898, 2001
10. Vlahou, A., Schellhammer, P. F., Mendrinos, S., Patel, K., Kondylis, F. I., Gong, L. et al: Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol, 158: 1491, 2001
11. Cazares, L. H., Adam, B. L., Ward, M. D., Nasim, S., Schellhammer, P. F., Semmes, O. J. et al: Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res, 8: 2541, 2002
12. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M. et al: Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359: 572, 2002
13. Adam, B. L., Qu, Y., Davis, J. W., Ward, M. D., Clements, M. A., Cazares, L. H. et al: Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res, 62: 3609, 2002
14. Breiman, L., Friedman, J. H., Olshen, R. A. and Stone, C. J.: Classification and Regression Trees. Belmont, California: Wadsworth Publishing Co., Inc., 1984
15. Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y. and Chan, D. W.: Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem, 48: 1296, 2002
16. Petricoin, E. F., 3rd, Ornstein, D. K., Paweletz, C. P., Ardekani, A., Hackett, P. S., Hitt, B. A. et al: Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst, 94: 1576, 2002
17. Kurella, M., Hsiao, L. L., Yoshida, T., Randall, J. D., Chow, G., Sarang, S. S. et al: DNA microarray analysis of complex biologic processes. J Am Soc Nephrol, 12: 1072, 2001
18. Lisboa, P. J.: A review of evidence of health benefit from artificial neural networks in medical intervention. Neural Netw, 15: 11, 2002
19. Raudy, S. S.: How good are support vector machines? Neural Netw, 13: 17, 2000